: LMPs dose-dependently inhibited cell proliferation of bone marrow-derived macrophages (BMDM). With the techniques support from Dr. Jean-François Cailhier (University of Montreal), we isolated the bone marrow-derived macrophages (BMDM) from femurs of C57BL/6 mice by standard sterile techniques. BMDM were matured for 7 days in Dulbecco's modified Eagle's medium (Wisent Inc., St-Bruno, Quecbec, Canada) with 10% FBS (Wisent Inc.), penicillin/streptomycin (100 mg/ml) (Wisent Inc.) , and 20% L929 cellconditioned medium as a source of macrophage-colony stimulating factor. (A) Indicated concentrations of LMPs were incubated with BMDM for 24 hours. The proliferation of macrophages was determined using 3 H-thymidine incorporation and values were presented as a percentage of control (CTL). *P < 0.05 vs. CTL. (B) Representative results of flow cytometry analysis of BMDM cell apoptosis after 24-hour treatment with indicated concentrations of LMPs, or staurosporine (positive control). FACS analysis was performed after macrophages were stained with Annexin-FITC and propidium iodide using Vybrant Apoptosis assay kit. Note that the staurosporin-treated cells undergo apoptosis and become PI+/Annexin V+ in the later stages of apoptosis. RNAs were isolated and subjected to RT 2 PCR Array analysis using a mouse angiogenesis array (PAMM-024) kit from SABioscience. The values were presented as fold changes relative to control genes set as 1.
